INTRODUCTION
In 2003, the ABPI established an office in Wales to represent the views of the industry and also reflect the importance of the devolved powers of the Welsh Assembly Government, particularly in relation to health and economic development.
ABPI Cymru Wales assists with the industry understanding of the evolving differences between Wales and the other home nations and contributes to Wales-only bodies, such as the All Wales Medicines Strategy Group and the NHS Industry Forum. The Staff at ABPI Cymru Wales participate in and monitor policy decisions that are likely to impact on the whole of the UK.
The ABPI Cymru Wales Industry Group (WIG) was formed in 2001 and is the voice and forum for the pharmaceutical industry in Wales. The ABPI Cymru Wales office supports the Group in this aim. Since its formation, WIG has been working in partnership with the National Assembly for Wales, NHS Wales and other key stakeholders, to help address the distinctive health needs of the people of Wales.
WIG currently has 32 member companies – having risen significantly in recent years to reflect the recognition within the industry of the growing importance and distinctiveness of the health agenda in Wales. Member companies include all the major global companies and smaller companies with a strong presence in Wales.
ABPI
CYMRU WALES